Dr Anna Kirby is current President of the European Society for Radiotherapy and Oncology (ESTRO) which facilitates radiation oncology research dissemination, education, training, interdisciplinary collaboration, professional support and advocacy both in Europe and beyond.
She studied Medical Sciences with psychology at Cambridge University and subsequently trained in clinical oncology at the Royal Marsden, UK becoming a Consultant Clinical Oncologist there in 2009 specialising in radiotherapy for patients with breast cancer. She leads research into novel breast radiotherapy techniques at The Royal Marsden and Institute of Cancer Research (ICR), London and was recently appointed as a Reader at the ICR. She is Technical Radiotherapy Lead for the UK Breast Proton Trial (PARABLE), Chief Investigator of the UK HeartSpare studies, Chief Clinical Co-ordinator of the IMPORT breast radiotherapy trials, and Breast Lead Investigator on the CORE trial evaluating the role of stereotactic radiotherapy in treating oligometastatic disease. She has a track record in investigating pragmatic innovations and translating these promptly into the clinic.